Alnylam details Cambridge expansion
November 9, 2007 11:42 AM
E-mail|
|Comments
()|
Text size
–
+
Alnlyam Pharmaceuticals Inc. is expanding.
The biotech company subleased 22,456 square feet from Archemix Corp. at 300 Third St. in Cambridge, where Alnylam is based, according to a filing with the Securities and Exchange Commission this week.
That's in addition to the 62,000 square feet of office and laboratory space Alnylam had already leased in the building.
The latest lease runs through September 2011, with an option to extend it for another four years.
(By Todd Wallack, Globe staff)
Comment
Permalink
E-mail
